Retatrutide is a groundbreaking pharmaceutical being investigated as a potential treatment for type 2 diabetes. This revolutionary approach belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor https://ztndz.com/story27322471/retatrutide-a-novel-treatment-for-type-2-diabetes